Last reviewed · How we verify
DMT-Low Dose
At a glance
| Generic name | DMT-Low Dose |
|---|---|
| Sponsor | Deepak C. D'Souza |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DMT-Low Dose CI brief — competitive landscape report
- DMT-Low Dose updates RSS · CI watch RSS
- Deepak C. D'Souza portfolio CI